• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种新型犬乳腺肿瘤细胞系中蛋白标志物表达、致瘤性和多柔比星化疗耐药性的特征。

Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.

出版信息

BMC Vet Res. 2014 Sep 30;10:229. doi: 10.1186/s12917-014-0229-0.

DOI:10.1186/s12917-014-0229-0
PMID:25267010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4189743/
Abstract

BACKGROUND

Canine mammary tumors (CMTs) are the most common type of cancer found in female dogs. Establishment and evaluation of tumor cell lines can facilitate investigations of the biological mechanisms of cancer. Different cell models are used to investigate genetic, epigenetic, and cellular pathways, cancer progression, and cancer therapeutics. Establishment of new cell models will greatly facilitate research in this field. In the present study, we established and characterized two new CMT cell lines derived from a single CMT.

RESULTS

We established two cell lines from a single malignant CMT specimen: DTK-E and DTK-SME. Morphologically, the DTK-E cells were large, flat, and epithelial-like, whereas DTK-SME cells were round and epithelial-like. Doubling times were 24 h for DTK-E and 18 h for DTK-SME. On western blots, both cell lines expressed cytokeratin AE1, vimentin, cytokeratin 7 (CK7), and heat shock protein 27 (HSP27). Moreover, investigation of chemoresistance revealed that DTK-SME was more resistant to doxorubicin-induced apoptosis than DTK-E was. After xenotransplantation, both DTK-E and DTK-SME tumors appeared within 14 days, but the average size of DTK-SME tumors was greater than that of DTK-E tumors after 56 days.

CONCLUSION

We established two new cell lines from a single CMT, which exhibit significant diversity in cell morphology, protein marker expression, tumorigenicity, and chemoresistance. The results of this study revealed that the DTK-SME cell line was more resistant to doxorubicin-induced apoptosis and exhibited higher tumorigenicity in vivo than the DTK-E cell line. We anticipate that the two novel CMT cell lines established in this study will be useful for investigating the tumorigenesis of mammary carcinomas and for screening anticancer drugs.

摘要

背景

犬乳腺肿瘤(CMTs)是女性犬中最常见的癌症类型。建立和评估肿瘤细胞系可以促进对癌症生物学机制的研究。不同的细胞模型用于研究遗传、表观遗传和细胞途径、癌症进展和癌症治疗学。建立新的细胞模型将极大地促进该领域的研究。在本研究中,我们从单个 CMT 中建立并鉴定了两种新的 CMT 细胞系。

结果

我们从单个恶性 CMT 标本中建立了两种细胞系:DTK-E 和 DTK-SME。形态上,DTK-E 细胞大而扁平,呈上皮样,而 DTK-SME 细胞呈圆形,呈上皮样。DTK-E 的倍增时间为 24 小时,DTK-SME 的倍增时间为 18 小时。在 Western blot 上,两种细胞系均表达细胞角蛋白 AE1、波形蛋白、细胞角蛋白 7(CK7)和热休克蛋白 27(HSP27)。此外,对化疗耐药性的研究表明,DTK-SME 对阿霉素诱导的细胞凋亡的耐药性高于 DTK-E。异种移植后,DTK-E 和 DTK-SME 肿瘤均在 14 天内出现,但 56 天后 DTK-SME 肿瘤的平均大小大于 DTK-E 肿瘤。

结论

我们从单个 CMT 中建立了两种新的细胞系,它们在细胞形态、蛋白标志物表达、致瘤性和化疗耐药性方面表现出显著的多样性。本研究的结果表明,与 DTK-E 细胞系相比,DTK-SME 细胞系对阿霉素诱导的细胞凋亡的耐药性更高,体内致瘤性更强。我们预计本研究中建立的两种新型 CMT 细胞系将有助于研究乳腺癌的发生机制,并用于筛选抗癌药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/46e2130d6ace/12917_2014_229_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/bc0f977243bc/12917_2014_229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/7afca6092a6e/12917_2014_229_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/15e9f9a927ba/12917_2014_229_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/457e5dde7831/12917_2014_229_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/5feaabcaca00/12917_2014_229_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/035b4a6a5783/12917_2014_229_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/46e2130d6ace/12917_2014_229_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/bc0f977243bc/12917_2014_229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/7afca6092a6e/12917_2014_229_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/15e9f9a927ba/12917_2014_229_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/457e5dde7831/12917_2014_229_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/5feaabcaca00/12917_2014_229_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/035b4a6a5783/12917_2014_229_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/4189743/46e2130d6ace/12917_2014_229_Fig7_HTML.jpg

相似文献

1
Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.两种新型犬乳腺肿瘤细胞系中蛋白标志物表达、致瘤性和多柔比星化疗耐药性的特征。
BMC Vet Res. 2014 Sep 30;10:229. doi: 10.1186/s12917-014-0229-0.
2
Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F.犬热休克蛋白27促进犬类细胞系DTK-F的增殖、迁移及对阿霉素的抗性。
Vet J. 2015 Aug;205(2):254-62. doi: 10.1016/j.tvjl.2015.02.023. Epub 2015 Mar 5.
3
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.三种新型犬乳腺肿瘤细胞系的致瘤性和药物敏感性评估。
Res Vet Sci. 2010 Apr;88(2):285-93. doi: 10.1016/j.rvsc.2009.08.006. Epub 2009 Sep 11.
4
Bupivacaine induces apoptosis through caspase-dependent and -independent pathways in canine mammary tumor cells.布比卡因通过半胱天冬酶依赖性和非依赖性途径诱导犬乳腺肿瘤细胞凋亡。
Res Vet Sci. 2015 Jun;100:232-8. doi: 10.1016/j.rvsc.2015.03.024. Epub 2015 Mar 25.
5
Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.建立并鉴定一种 HER2 富集型犬乳腺癌肌上皮细胞系。
BMC Vet Res. 2023 Jan 30;19(1):22. doi: 10.1186/s12917-023-03573-9.
6
Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.德拉考昔与阿霉素对犬乳腺肿瘤细胞系CMT-U27的协同生长抑制作用。
J Vet Med Sci. 2016 May 3;78(4):657-68. doi: 10.1292/jvms.15-0387. Epub 2016 Jan 29.
7
Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.犬乳腺腺癌细胞系衍生球体的特征。
Res Vet Sci. 2011 Oct;91(2):254-60. doi: 10.1016/j.rvsc.2010.11.016. Epub 2010 Dec 28.
8
Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors.犬乳腺肿瘤多药耐药细胞系的建立与鉴定
Front Vet Sci. 2023 Mar 30;10:1129756. doi: 10.3389/fvets.2023.1129756. eCollection 2023.
9
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.甲状腺球蛋白作为犬和人乳腺肿瘤中恶性肿瘤的阴性标志物。
Mol Carcinog. 2021 Jul;60(7):455-468. doi: 10.1002/mc.23304. Epub 2021 May 18.
10
Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.一种新的犬乳腺肿瘤细胞系FR37-CMT的永生化及特性研究
Vet Comp Oncol. 2017 Sep;15(3):952-967. doi: 10.1111/vco.12235. Epub 2016 May 3.

引用本文的文献

1
Establishment and Partial Characterization of Canine Mammary Tumor Cell Lines.犬乳腺肿瘤细胞系的建立及部分特性研究
Animals (Basel). 2025 Jul 7;15(13):1991. doi: 10.3390/ani15131991.
2
The Anticancer Effect of Genistein Through Enhancing PERK Signaling and Suppressing the IRE1α-XBP1 Axis in Canine Mammary Gland Tumor Cells.染料木黄酮通过增强PERK信号传导和抑制犬乳腺肿瘤细胞中的IRE1α-XBP1轴发挥抗癌作用。
Animals (Basel). 2025 Jun 10;15(12):1717. doi: 10.3390/ani15121717.
3
Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells.

本文引用的文献

1
Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.蛋白质组学分析表明,白藜芦醇抑制 HSP27 的表达,并增强乳腺癌细胞对阿霉素治疗的敏感性。
PLoS One. 2013 May 27;8(5):e64378. doi: 10.1371/journal.pone.0064378. Print 2013.
2
Hsp-27 expression in invasive ductal breast carcinoma.热休克蛋白27在乳腺浸润性导管癌中的表达
Folia Histochem Cytobiol. 2012;50(4):527-33. doi: 10.5603/16717.
3
Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2.
姜烯酚和虾青素对阿霉素细胞毒性的表观遗传免疫调节作用在激素阳性乳腺癌细胞中。
BMC Pharmacol Toxicol. 2021 Jan 28;22(1):8. doi: 10.1186/s40360-021-00473-2.
4
Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability and .具有血管生成拟态能力的犬乳腺癌细胞系的建立与鉴定 以及 。 (原文最后似乎不完整)
Front Vet Sci. 2020 Oct 27;7:583874. doi: 10.3389/fvets.2020.583874. eCollection 2020.
5
In vitro comparative models for canine and human breast cancers.犬类和人类乳腺癌的体外比较模型。
Clujul Med. 2016;89(1):38-49. doi: 10.15386/cjmed-519. Epub 2016 Jan 15.
6
Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.一种新的犬炎性乳腺癌细胞系IPC-366的建立与鉴定
PLoS One. 2015 Mar 25;10(3):e0122277. doi: 10.1371/journal.pone.0122277. eCollection 2015.
将姐妹鼠乳腺肿瘤细胞系 HH-16 cl.2/1 和 HH-16.cl.4 定义为 Erbb2 的体外细胞模型。
PLoS One. 2012;7(1):e29923. doi: 10.1371/journal.pone.0029923. Epub 2012 Jan 10.
4
Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.热休克蛋白 27 通过调节上皮-间充质转化和核因子-κB 参与乳腺癌干细胞的维持。
Breast Cancer Res. 2011 Oct 24;13(5):R101. doi: 10.1186/bcr3042.
5
Keratin 7 expression in colorectal cancer--freak of nature or significant finding?结蛋白 7 在结直肠癌中的表达——自然的怪胎还是重要的发现?
Histopathology. 2011 Aug;59(2):225-34. doi: 10.1111/j.1365-2559.2011.03694.x.
6
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
7
Lung cancer cell lines as tools for biomedical discovery and research.肺癌细胞系作为生物医学发现和研究的工具。
J Natl Cancer Inst. 2010 Sep 8;102(17):1310-21. doi: 10.1093/jnci/djq279. Epub 2010 Aug 2.
8
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.三种新型犬乳腺肿瘤细胞系的致瘤性和药物敏感性评估。
Res Vet Sci. 2010 Apr;88(2):285-93. doi: 10.1016/j.rvsc.2009.08.006. Epub 2009 Sep 11.
9
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.乳腺癌细胞系的分子图谱定义了相关的肿瘤模型,并为癌症基因发现提供了资源。
PLoS One. 2009 Jul 3;4(7):e6146. doi: 10.1371/journal.pone.0006146.
10
Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid.源自人转移性中肠类癌的三种新型细胞系——P-STS、L-STS、H-STS的建立与鉴定
Anticancer Res. 2009 Jun;29(6):1951-61.